BioSpace News Archive

AB Science SA reports its revenues for the year 2023 and provides an update on its activities.

Transformative Biotech, LLC, a molecular diagnostics technology company, announced the appointment of Dr. Barbara Handelin as Co-CEO and to its Board of Directors.

Recent advancements signify a new era in liver disease diagnosis and treatment.

The brain implants market size exceeded USD 5.85 billion in 2022 and is expected to capture USD 14.24 billion by 2032, rising at a healthy CAGR of 9.3% from 2023 to 2032.

According to a recent report by nova one advisor, the U.S. compounding pharmacies market size was exhibited at USD 5.95 billion in 2023 and is projected to hit around USD 10.76 billion by 2033, growing at a CAGR of 6.1% during the forecast period 2024 to 2033.

Avenue Therapeutics, Inc. today reported financial results and recent corporate highlights for the first quarter ended March 31, 2024.

PaxMedica, Inc. today announced it has timely filed a formal notice of appeal with the Nasdaq Office of Appeals and Review to reverse the decision of a Nasdaq Hearings Panel to delist the Company from Nasdaq.

ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA, or “ZyVersa”), a clinical-stage specialty biopharmaceutical company developing first-in-class drugs for the treatment of renal and inflammatory diseases with high unmet medical needs, reports financial results for the quarter ended March 31, 2024 and provides business update.

Actinium Pharmaceuticals, Inc. today announced it will host a KOL webinar on Monday, May 20, 2024, at 8:00 AM ET.

Genomics solutions provider Integrated DNA Technologies (IDT) and Bio-IT company Molecular Health have entered into a global multi-year agreement, starting in the U.S., to integrate their next generation sequencing (NGS) capabilities.